Holen Sie sich die Stockscreener-App
10.99
1.76%
0.19
Handel nachbörslich:
10.98
-0.010
-0.09%
Schlusskurs vom Vortag:
$10.80
Offen:
$10.71
24-Stunden-Volumen:
213.04K
Relative Volume:
0.32
Marktkapitalisierung:
$234.94M
Einnahmen:
$66.59M
Nettoeinkommen (Verlust:
$-104.93M
KGV:
-2.2202
EPS:
-4.95
Netto-Cashflow:
$-96.48M
1W Leistung:
+0.27%
1M Leistung:
-0.81%
6M Leistung:
+117.19%
1J Leistung:
-3.17%
1-Tages-Spanne:
$10.22
$11.00
1-Wochen-Bereich:
$10.22
$11.34
52-Wochen-Spanne:
$4.09
$15.34
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
Firmenname
Enanta Pharmaceuticals Inc
Sektor
Branche
Telefon
617 607 0800
Adresse
4 KINGSBURY AVENUE, WATERTOWN, MA
Vergleichen Sie ENTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
10.99 | 311.61M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2025-07-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-08-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-08-08 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-01-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-11-24 | Eingeleitet | Evercore ISI | Underperform |
| 2020-08-28 | Fortgesetzt | ROTH Capital | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-05-24 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-23 | Hochstufung | Berenberg | Hold → Buy |
| 2018-12-13 | Eingeleitet | Berenberg | Hold |
| 2018-06-06 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-11 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Bestätigt | Barclays | Underweight |
| 2015-10-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2015-10-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
Alle ansehen
Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten
How Enanta Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Is Enanta Pharmaceuticals Inc. stock positioned well for digital economyMarket Trend Summary & Stepwise Swing Trade Plans - newser.com
Is Enanta Pharmaceuticals Inc. stock ready for a breakoutWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com
What does recent volatility data suggest for Enanta Pharmaceuticals Inc.Exit Point & Risk Adjusted Swing Trade Ideas - newser.com
What dividend safety score for Enanta Pharmaceuticals Inc. stockWeekly Gains Summary & Low Risk High Reward Ideas - fcp.pa.gov.br
Will breakout in Enanta Pharmaceuticals Inc. lead to full recoveryJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
How Enanta Pharmaceuticals Inc. stock compares to growth peersRisk Management & Daily Profit Maximizing Tips - newser.com
How reliable is Enanta Pharmaceuticals Inc. (9EP) stock dividend growthPortfolio Gains Report & Risk Controlled Daily Plans - newser.com
How to use a screener to detect Enanta Pharmaceuticals Inc. breakouts2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
How strong is Enanta Pharmaceuticals Inc. stock balance sheet2025 Market WrapUp & Free Weekly Watchlist of Top Performers - fcp.pa.gov.br
What sentiment indicators say about Enanta Pharmaceuticals Inc. stockJuly 2025 Market Mood & Weekly Momentum Picks - newser.com
How to forecast Enanta Pharmaceuticals Inc. trends using time series2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Why Enanta Pharmaceuticals Inc. (9EP) stock gets analyst attentionQuarterly Earnings Report & Fast Exit and Entry Trade Guides - newser.com
What moving averages say about Enanta Pharmaceuticals Inc.Portfolio Update Summary & Free Fast Gain Swing Trade Alerts - newser.com
Enanta Pharmaceuticals to Participate in Upcoming Investor ConferencesNovember 4, 2025 - BioSpace
Can Enanta Pharmaceuticals Inc. (9EP) stock deliver strong annual returnsStop Loss & Daily Chart Pattern Signal Reports - newser.com
How Enanta Pharmaceuticals Inc. stock performs in rising dollar environmentMarket Movers & AI Enhanced Execution Alerts - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has caught the attention of institutional investors who hold a sizeable 44% stake - Yahoo Finance
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
In this photo illustration, the Enanta Pharmaceuticals, Inc. logo is... News Photo - Getty Images
What the charts say about Enanta Pharmaceuticals Inc. todayTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Why Enanta Pharmaceuticals Inc. stock is rated strong buyLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
Using Ichimoku Cloud for Enanta Pharmaceuticals Inc. technicals2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Tools to assess Enanta Pharmaceuticals Inc.’s risk profile2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Is Enanta Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Trade Ideas & Verified Entry Point Detection - newser.com
Trend analysis for Enanta Pharmaceuticals Inc. this weekJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Is Enanta Pharmaceuticals Inc. stock a good choice for value investorsStock Surge & Stock Portfolio Risk Control - newser.com
Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):